











The Rho family of small GTPases constitute a branch of the
Ras superfamily that are essential regulators of actin
cytoskeleton organization, gene expression, cell cycle
progression and activation of NADPH oxidase (Hall, 1998;
Mackay & Hall, 1998; Kaibuchi et al. 1999). The Rho
family GTPases consist of more than 15 members that
include isoforms of Rho, Rac, Cdc42 and TC10. Like
related GTPases, Rho family GTPases are activated by
guanine nucleotide exchange factors (GEFs) that stimulate
GDP–GTP exchange, as well as inactivated by GTPase
activation proteins (GAPs) and by nucleotide dissociation
inhibitor proteins (RhoGDIs). Regulated by their
GTP/GDP bound state, RhoA, Rac1 and Cdc42 act as
molecular switches whose downstream effectors include
serine/threonine kinases (e.g. p21 activated kinase, PKN
and Rho kinase), tyrosine kinases (MLK3) and lipid
kinases (e.g. phosphatidylinositol 4-phosphate 5-kinase).
Rho family GTPases exhibit significant hierarchical and
regulatory interactions, although Rho, Rac and Cdc42
promote notably different morphological changes of cells
through selective actions on cytoskeletal reorganization
(Ridley & Hall, 1992; Hall, 1994; Nobes & Hall, 1995).
A dense network of F-actin filaments, termed cortical
actin, adjacent to the plasma membrane has been
proposed to act as a barrier that prevents access of
secretory vesicles to the membrane, but also to serve as a
structural component that is essential to orchestrate
recruitment and resupply of secretory vesicles to a readily
releasable pool (Cheek & Burgoyne, 1986; Nakata &
Hirokawa, 1992; Trifaro et al. 1992b; Trifaro & Vitale,
1993; Muallem et al. 1995; Chowdhury et al. 1999; Lang et
al. 2000). Activation of exocytosis in several secretory cell
types, including chromaffin cells (Vitale et al. 1995;
Tchakarov et al. 1998), mast cells (Norman et al. 1994),
synaptosomes (Bernstein & Bamburg, 1985), and
pancreatic acinar cells (Jungermann et al. 1995) results in
transient cortical F-actin disassembly followed by
reassembly. The reorganizing of cortical actin structure
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during the secretory process has implicated Rho family
GTPases as potentially critical regulators of calcium-
dependent secretory pathway(s) (Pinxteren et al. 2000).
Indeed, the effects of Rac, Cdc42 and Rho to regulate GTP-
and/or Ca2+-dependent degranulation in mast cells and in
the HL-60 mast cell line has been extensively investigated
(Norman et al. 1996; O’Sullivan et al. 1996; Prepens et al.
1996; Guillemot et al. 1997; Brown et al. 1998; Hong-
Geller & Cerione, 2000; Pinxteren et al. 2000). In neurons
and neuroendocrine cells evidence for a role of these
GTPases in neurosecretion is largely based on effects of
clostridial toxins that inhibit RhoGTPase family members.
Cdc42 and/or Rac have been implicated in regulation of
pancreatic b cell (Kowluru et al. 1997), PC12 cell (Frantz et
al. 2002) and adrenal chromaffin cell (Gasman et al. 1999)
secretion and in acetylcholine release from Aplysia
neurons (Doussau et al. 2000; Humeau et al. 2002). By
comparison, most evidence suggests Rho exerts little
regulatory influence on the secretory pathway (Kowluru et
al. 1997; Gasman et al. 1999). However, to date there has
been no evaluation of the extent to which these GTPases
are activated by secretory stimuli.
A focus of the present investigation was to determine if the
level of Rac1 or Cdc42 activation was altered in response to
secretagogue activation of secretion, as would be expected of
a dynamic mediator of the Ca2+-dependent neurosecretory
pathway. As Rac1, but not Cdc42, was activated we further
examined the relationship of Rac1 activation to functional
effects on Ca2+-dependent neurosecretion by expression of
mutants of Rac1 that are maintained in constitutively active
(GTP-bound) or inactive (GDP-bound) conformations.
Finally, we evaluated if Rac1-mediated regulation of the
secretory pathway was mechanistically related to
cytoskeletal reorganization by expression Rac1 effectors and
effector domain mutants as well as by pharmacological
alterations of cortical actin.
METHODS 
Materials
Phalloidin, latrunculin-A, jasplakinolide, Alexa Fluor 568-
conjugated phalloidin, tetramethylrhodamine-linked goat anti-
mouse IgG, Alexa 488-linked goat anti-rabbit IgG and Alexa 488-
conjugated goat anti-mouse IgG were from Molecular Probes.
Monoclonal antibody against human Rac1 was from Upstate
Biotechnology Inc. (Lake Placid, NY, USA) (c23A8). Anti-human
RhoGDI antibody (c7) was from Transduction Laboratories
(Lexington, KY, USA). Rabbit polyclonal anti-human Cdc42
(SC87) was from Santa Cruz Biotechnology (Santa Cruz, CA,
USA). Mouse monoclonal antibody against c-myc epitope tag
(9E10) was from DSHB (Developmental Studies Hybridoma
Bank, Iowa City, IA, USA) while anti-HA epitope tag antibody was
from Berkeley Antibody Company (Richmond, CA, USA). The
rabbit polyclonal dopamine-b-hydroxylase (DBH) antibody was
from Dr Patrick J. Fleming (Georgetown University Medical
Center, Washington, DC, USA). All the other chemicals were
obtained from Sigma.
Plasmids
Mammalian expression plasmid pcDNA/HA-Rac1-V12,
pEBG/GST–RacV12, pEBG/GST–RacN17 and pRK5/myc-RhoGDI,
were kindly provided by Dr L.-H. Tsai (Harvard Medical School;
Howard Hughes Medical Institute). pcDNA/3xHA-RacN17 was
purchased from Guthrie Research Institute (Sayre, PA, USA).
Effector domain mutants of pcDNA/HA-Rac1-V12 (T35S, Y40H,
F37L) were constructed using the PCR-based Quickchange Site-
Directed Mutagenesis kit from Stratagene (Cedar Creek, TX,
USA). pCR3.1/ADF wild-type from chicken was from Dr James R.
Bamburg. pcDNA/ANP–EmGFP, a granule-targeted ANP
protein gene fused to an emerald version of green fluorescent
protein (EmGFP) was from Dr Edwin Levitan (University of
Pittsburgh, Pittsburgh, PA, USA). The GST-containing bacterial
expression plasmid pGEX/GST–PAKPBD, which contains
glutathione-S-transferase fused to the GTPase binding domain of
human p21-activated kinase 1 (GST–PAKPBD) as well as
pCMV6M/myc-hPAK1 has been described previously (Benard et
al. 1999).
Preparation and culture of bovine chromaffin cells
Bovine adrenal glands were rinsed by gentle injection via the renal
vein of a divalent metal-ion-free Locke’s (DMF-Locke’s) which
contained (mM): 145 NaCl, 10 Hepes, 10 glucose, 5.6 KCl, 3.5
NaHCO3, with 100 units ml
_1 penicillin, 100 µg ml_1
streptomycin, pH 7.4. Each gland was then injected with 5 ml of a
pre-warmed 0.5 % collagenase–DMF-Locke’s and gently shaken
for 0.5 h at 37 oC. This collagenase digestion step was repeated
once. The medullary tissue was then isolated into 15 ml of a 0.5 %
(w/v) collagenase solution and the tissue minced prior to gentle
shaking for 30 min at 37 oC. The digested tissue was then passed
through a 250 µm gauge nylon mesh and diluted in cold DMF-
Locke’s. The cells were then pelleted (100 g, 3 min, 4 oC), washed
twice in DMF-Locke’s and resuspended into 100 ml of 14 % (v/v)
sterile renograffin (Bracco Diagnostics, Princeton, NJ, USA). The
cell suspension was loaded under 7.25 % renograffin in DMF-
Locke’s and centrifuged at 1500 g for 10 min at room
temperature. The interface was collected and mixed with an equal
volume of sterile saline containing (mM): 2.2 CaCl2, 1 MgCl2,
145 NaCl, 10 Hepes, 10 glucose, 5.6 KCl, 3.5 NaHCO3, with
100 units ml_1 penicillin, 100 µg ml_1 streptomycin, pH 7.4. The
cell suspension was pelleted (500 g, 3 min, 20 oC), washed once
and then resuspended in Dulbecco’s modified Eagle’s
medium–F-12 containing 10 % fetal bovine serum (GIBCO BRL
Life Technologies), 100 units ml_1 penicillin, 100 µg ml_1
streptomycin, 10 µg ml_1 gentamicin, 1 µM cytosine b-D-arabino-
furanoside and 2.5 µg ml_1 fungizone. Cells were plated into
collagen-coated 35 mm wells at a density of 3 w 106 cells per well.
All experiments were performed on cells cultured between 3 and
8 days. One day prior to use, medium was replaced with
fungizone-free DMEM–F-12.
Cell fractionation
Chromaffin cells (8 w 106 cells) were placed in Ca-PSS (mM:
118 NaCl, 25 NaHCO3, 1.13 MgCl2, 5 KCl, 1 Na2HPO4, 10 glucose
and 2.2 CaCl2, pH 7.4) and stimulated with 20 mM of the nicotinic
acetylcholine receptor agonist 1,1-dimethyl-4-phenyl-
piperazinium iodide (DMPP) for 3 min at 30 °C. Control cells
received no stimulation. The Ca-PSS was then removed, ice-cold
fractionation buffer added (mM: 25 Tris-HCl, 50 NaCl, 1 EDTA,
pH 7.5) and the cells rapidly collected. The cells were then
sonicated on ice for 5 s at 7 W power output (Sonic
Dismembrator Model 100, Fisher Scientific). The lysate was then
subjected to centrifugation at 1000 g for 10 min and the resulting












supernatant subjected to a further centrifugation at 100 000 g for
30 min. The 100 000 g pellet containing membrane fraction was
solubilized with lysis buffer (mM: 25 Tris-HCl, 100 NaCl, 5 MgCl2,
1 dithiothreitol (DTT), with 5 % glycerol, 1 % Nonidet P-40
(Sigma), and a protease inhibitor cocktail consisting of 4 µg ml_1
leupeptin, 4 µg ml_1 aprotinin, 4 µg ml_1 pepstatin (Roche
Diagnostics) and 1 mM phenylmethylsulfonyl fluoride (PMSF,
Sigma)). Both the solubilized membrane fraction (particulate)
and the 100 000 g supernatant containing the cytosol were
subjected to SDS-PAGE and immunoblotting.
Cell transfection
Chromaffin cells were transfected with plasmid coated 1.0 µm
diameter gold beads using a Helios Gene Gun (Bio-Rad
Laboratories). The gold beads were prepared according to the
manufacturer’s instructions. The level of recombinant protein
expression was achieved by controlling the plasmid concentration
applied to the gold beads. For each of the constructs used we
examined the effects of three plasmid concentrations on basal and
evoked secretion. For the constitutively active constructs, the
lowest plasmid concentration that gave an effect (0.5 µg per 20 mg
beads) was used. For dominant negative Rac1-N17, plasmid
concentrations up to 50 µg per 20 mg beads were tested. The time
allowed for protein expression following transfection was held
constant at 3 days.
GST-tagged fusion protein expression and purification
Recombinant GST–PAKPBD fusion protein was expressed in
E. coli (BL21 codon plus RIL) and purified by glutathione-linked
Sepharose 4B (Pharmacia Biotech Inc.) as previously described
(Shuang et al. 1998). GST fusion protein was eluted from the
Sepharose beads in 300 µl elution buffer (mM: 10 glutathione, 50
Tris-HCl, pH 8.0) and dialysed in a 10 kDa molecular weight
cutoff cassette (Pierce, Rockford IL, USA) overnight against
(mM): 25 Tris-HCl, 2 DTT, 1 MgCl2, with 2.5 % glycerol, pH 7.5.
The GST-fusion protein was then collected, diluted in
1.7 w storage buffer (mM: 50 Hepes, 150 NaCl, 5 MgCl2, 5 DTT,
with 50 % glycerol) and kept at _20 °C until use.
Rac and Cdc42 activation assay
Culture media were replaced with Ca-PSS and the cells
preincubated (5 % CO2, 37
oC) for 1 h. Cells were then stimulated
with 50 mM K+ in a modified Ca-PSS, or with 20 µM DMPP in Ca-
PSS. For 50 mM K+ stimulation, an equal volume of a 2 w 50K/Ca-
PSS solution (containing, mM: 23 NaCl, 25 NaHCO3, 1.13 MgCl2,
100 KCl, 1 Na2HPO4, 10 glucose and 2.2 CaCl2, pH 7.4) was added
to the dish. For 20 µM DMPP stimulation, an equal volume of Ca-
PSS containing 40 µM DMPP was added. The cells were then
incubated for a given time period. Aspiration of the stimulation
buffer and addition of 0.5 ml ice-cold lysis buffer containing
100 µg ml_1 GST–PAKPBD terminated stimulation. The cell
lysate was collected and immediately centrifuged at 5000 g for
5 min at 4 oC. The supernatant was removed and mixed with 0.5
ml binding buffer (mM: 25 Tris-HCl, pH 7.5, 40 NaCl, 30 MgCl2, 1
DTT, with 0.5 % Nonidet P-40) to which 12 µl of
glutathione–Sepharose 4B beads (Pharmacia Biotech) were
added. The tubes were rotated for 45 min at 4 oC prior to
collection of the beads (500 g, 3 min). The bead pellet was washed
twice with 1 ml binding buffer followed by two washes with TNM
buffer (mM: 50 Tris-HCl, pH 7.5, 50 NaCl and 5 MgCl2). The final
bead pellet was resuspended in Laemmli sample buffer (Laemmli,
1970) and boiled. Proteins were separated by 10 % SDS-PAGE,
transferred to nitrocellulose membrane and blots probed for the
GTPase (Rac1 or Cdc42). Immunoreactivity was detected using
the ECL chemiluminescence system (Amersham Pharmacia
Biotech) in conjunction with a Fluor-S Max Multi-lmager system
(Bio-Rad) running Quantity One software.
Chromaffin cell secretion assays
Human growth hormone (hGH) secretion was measured from
transfected chromaffin cells using a highly sensitive
chemiluminescence assay kit from Nichols Institute (San Juan
Capistrano, CA, USA) as described previously (Wick et al. 1993).
Secretion data were averaged between experiments or cell
preparations by normalization of test responses to responses of
control hGH-transfected cells within each experiment. In each
case, cells were cotransfected with the hGH expression plasmid
and an expression plasmid carrying the construct of interest
and/or an empty vector parent plasmid (Neo). In experiments
with the F-actin stabilizing drug jasplakinolide (100 nM), the drug
was added to cell cultures 8 h prior to initiation of the hGH assay.
Use of co-expressed hGH as a marker of the regulated secretory
pathway allowed examination of recombinant Rac1 effects on
secretion from only those cells expressing the recombinant
GTPase protein. An assumption implicit with the approach, and
well substantiated by prior studies, is that properties of hGH
secretion closely mimic those of endogenous catecholamines
(Wick et al. 1993; Holz et al. 1994).
Secretion from digitonin-permeabilized chromaffin cells was
performed as previously described (Wick et al. 1993; Holz et al.
1994). Cells were permeabilized by incubation in KGEP solution
(mM: 139 potassium glutamate, 20 Pipes (pH 6.6), 1 MgCl2,
5 EGTA, 2 Mg-ATP, 0.2 Li-GTP, with 2.5 mg ml_1 BSA, 20 µM
digitonin) for 2 min at 30 oC. Cells were then stimulated for the
time specified with Ca/KGEP solution that omitted digitonin and
added 4.685 mM CaCl2 to set a final free calcium concentration (in
combination with EGTA) to 30 µM. hGH secreted into the
medium and total cell hGH content from transfected cells were
determined from aliquots following centrifugation at 500 g, for
10 min at 4 oC. In experiments assessing effects of F-actin drugs
(phalloidin and latrunculin-A) on permeabilized cells the drug
was added to the KGEP during both the permeabilization and
secretion phase of the protocol.
Electrophysiological recording of calcium current (ICa) and
membrane capacitance (Cm)
Conventional whole cell patch-clamp recording methods were
used to evoke and record ICa and measure time-resolved changes
in Cm (DCm) from single adrenal chromaffin cells using an
Axopatch 200A amplifier (Axon Instruments, Union City, CA,
USA) and phase-tracking software (Pulse Control; Drs Jack
Herrington and Richard Bookman, University of Miami Medical
School, Miami, FL, USA). The DCm was measured by applying a
sine wave (60 mV peak to peak at 1201 Hz) to a holding potential
of –90 mV. Sixteen samples per sinusoidal period were used to
compute one Cm point. Calibration pulses (100 fF) were generated
at the beginning of each trace. Currents were filtered at 5 kHz and
sampled at 20 µs. Series resistance and resting membrane
capacitance were compensated electronically. Baseline leak
current was subtracted prior to integration and recording was
terminated when leak current exceeded 10 % of the
depolarization-evoked calcium current. No corrections were
made for linear leak during step depolarization. A train of eight
step depolarizations from –90 to +10 mV at 0.2 s intervals was
used to evoke ICa and DCm. The duration of the step
depolarizations used for each train was generally 50 ms, although
in two control cells longer pulse durations were applied (75 and
150 ms) to generate approximately 10 pC calcium influx per step
depolarization. No significant differences were found between the












treatments with respect to current density (A F_1) using 50 ms step
depolarizations to +10 mV. Pipettes were constructed out of
1.5 mm outer diameter capillary glass (A-M Systems), coated with
Sylgard and fire polished to resistances of 1.5–4 MV. The pipette
soluion contained (mM): 128 N-methyl-D-glucamine-Cl, 40
Hepes, 10 NaCl, 2 Mg-ATP, 0.2 GTP, 0.25 Tris-EGTA, with pH
adjusted to 7.1. The extracellular solution contained (mM): 137
tetraethylammonium chloride, 10 CaCl2, 2 MgCl2, 10 Hepes and
19 glucose, with the pH adjusted to 7.2 with Tris. Chromaffin
cells were transfected 2–3 days prior to replating and
electrophysiological recording.
Immunocytochemistry and phalloidin staining
Chromaffin cells cultured on collagen-coated coverglasses were
fixed with 4 % paraformaldehyde–PBS for 30 min, quenched with
50 mM NH4Cl–PBS for 15 min, permeablized with 0.2 % Triton
X-100–PBS for 8–10 min, and blocked with 2 % BSA–PBS for
60 min. Following incubation in primary antibody at 1:200
dilution in 2 % BSA–PBS for 1 h, the cells were incubated with
fluorescein-labelled secondary antibody at 1:200 dilution for 1 h.
For co-staining of F-actin, 0.25 U ml_1 Alexa-conjugated
phalloidin was included in the secondary antibody solution.
Digital fluorescence images from cell cultures were viewed either
on a conventional Nikon epifluorescence microscope or with a
Zeiss LSM 510 confocal microscope, and processed using
Photoshop 6.0 software (Adobe Systems Inc., Mountain View,
CA, USA). Two controls were used to ensure specificity of
immunochemical reactivity. These include use of primary
antibody against relevant recombinant epitope tags in non-
transfected cells and use of secondary antibody alone on
transfected and non-transfected cells. Immunoreactivity and
fluorescent signals were quantified using NIH Image software.
Statistics
Data were generally calculated as a fraction of the control response
observed within each experiment. All data are plotted as the
mean ± S.E.M. All experiments were repeated on at least two, and
usually several different cell preparations. The n number refers to
the number of observations for each treatment/condition. For
normalization within experiments, all values were normalized
against the average value of the control group. Statistical
significance of treatments relative to control was determined
using Student’s unpaired t tests or for multiple comparisons using
ANOVA with Bartletts post hoc test on normally distributed data.
In the case of non-parametric data, a Mann-Whitney test was
performed using the original calculated values. Statistical analysis
was performed using GraphPad Instat software (GraphPad
Software Inc, San Diego, CA, USA).
RESULTS 
Effect of secretagogue stimulation of chromaffin
cells on activation of Rac1 and Cdc42
Figure 1A illustrates the presence of Rac1 and Cdc42 in
chromaffin cells from adrenal medulla. Chromaffin cells
were identified by co-localization of the catecholamine
biosynthetic enzyme dopamine-b-hydroxylase. Rac1 and
Cdc42 were predominantly localized to cytosol as well as
the plasma membrane. To investigate the level of Rac1 and
Cdc42 activation in chromaffin cells we used an assay based
on the protein binding domain (PBD) of human p21-
activated kinase 1 (PAK1) fused to GST. This protein
demonstrates selective affinity for the GTP-bound form
(i.e. active) of Rac1 and Cdc42, and does not bind Rho
(Benard et al. 1999). Figure 1B shows that a rapid and
transient activation of Rac1 occurred upon nicotinic ACh
(nACh) receptor activation with DMPP (20 µM), or
membrane depolarization with elevated K+ (50 mM).
Control cells showed no change in Rac1 activation.
Secretagogue-induced Rac1 activation peaked at
approximately 3 min and was followed by a return toward
baseline, where it remained elevated throughout a stimulus
period lasting up to 30 min. DMPP stimulation of the cells
also resulted in an increase in Rac1 immunoreactivity
found in a particulate fraction and decrease in the cytosolic
fraction relative to that of control cells (Fig. 1C). The shift
in distribution is consistent with activation being
coincident with translocation of activated Rac1 to
membrane-delimited compartments. Moreover, Rac1
activation was found to be Ca2+ sensitive. Stimulation with
elevated K+ (50 mM, 2 min) saline in the presence of Cd2+
(100 µM), a voltage-dependent Ca2+ channel blocker,
limited Rac1 activation to 28 ± 5 % (n = 6) of the level
observed without Cd2+ present. In comparison to Rac1, the
levels of GTP-bound Cdc42 were found not to significantly
increase in response to DMPP stimulation (Fig. 1D).
Transfection and expression of recombinant Rac1
To investigate the role of Rac1 in regulation of chromaffin
cell secretory responsiveness, we utilized transfection and
overexpression of dominant active (V12 and L61) and
dominant negative (N17) constructs of epitope-tagged
Rac1. Immunocytochemistry against the epitope tag
demonstrated successful transfection and expression of
the recombinant GTPase constructs (Fig. 2A). Co-
transfection of ANP–EmGFP, a fluorescent protein
directed to dense core secretory granules, demonstrated
that the recombinant Rac1 expression was localized to
chromaffin cells. Overexpression of specific Rho family
GTPases has the potential for binding upstream regulators
(e.g. GEFs) as well as downstream effectors of
corresponding members of this family. Therefore, care was
taken to limit levels of overexpression by initially titrating
the amount of plasmid DNA used for transfection in
chromaffin cells. As representative, Fig. 2B shows that the
concentration of plasmid DNA for RacV12 used in these
investigations resulted in modest levels of overexpression
(i.e. approximately 2.5-fold) of the recombinant protein
over endogenous Rac1.
Expressed recombinant Rac1 protein alters
secretory responsiveness in permeabilized
chromaffin cells
The effect of Rac1 on secretory responsiveness in
chromaffin cells was determined by expression of
dominant active (Rac1-V12, Rac1-L61) or dominant
negative (Rac1-N17) GTPases together with a plasmid
encoding human growth hormone (hGH), which acts as a












reporter for the regulated secretory pathway (Wick et al.
1993). A sensitive immunological assay for the detection of
secreted hGH allowed the properties of the secretory
response to be evaluated from the co-transfected cells
alone, despite low transfection efficiency. The effects of
mutant Rac1 protein on secretion were initially examined
in digitonin-permeabilized chromaffin cells. In this way,
effects of the overexpressed GTPases on secretion evoked
by directly increasing the free Ca2+ to 30 µM reflect an
effect of the mutant protein on the intracellular pathway
governing exocytosis and avert effects potentially
attributable to alteration in calcium signalling pathways.
Figure 3A compares a representative time course of hGH
secretion from cells expressing hGH alone or hGH in
combination with dominant active Rac1-V12. Expression
of Rac1-V12 enhanced the Ca2+-induced hGH secretory
response, but had no effect on Ca2+-independent (i.e.
basal) hGH secretion when compared to control cells
cotransfected with a parent pcDNA (Neo.) plasmid.
Figure 3B shows the averaged effects on evoked hGH
secretion measured at 15 min from cells expressing the
recombinant Rac1 proteins. Strong enhancement of Ca2+-
dependent secretion was found for cells expressing Rac1-
V12 and Rac1-L61 constructs. Rac1-N17, a dominant
negative Rac1 mutant, was found not to alter Ca2+-
dependent secretion relative to control. The enhancement
of Ca2+-dependent secretion by constitutively active Rac1
constructs indicates that Rac1 can act as a positive
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Figure 1. Effect of nicotinic acetylcholine receptor (nAChR) activation and membrane
depolarization on the level of GTP-bound Rac1 and Cdc42 in chromaffin cells
A, confocal images showing localization of endogenous a-Rac1 and a-Cdc42 immunoreactivity in
chromaffin cells cultured for 3 days. Chromaffin cells were identified by anti-dopamine-b-hydroxylase
reactivity as visualized with Alexa488-conjugated secondary antibody. Scale bar = 10 µm. B, time course of
Rac1 activation in response to DMPP (20 µM)-mediated nAChR activation (0, n = 5) or elevated K+-
induced membrane depolarization (•, n = 9). Control cells (1, n = 8) from same cell preparations were
handled identically, but without stimulation. C, distribution of Rac1 immunoreactivity among cytosol and
membrane fractions (particulate) under control conditions and following stimulation with DMPP (20 µM,
2 min, n = 5). D, time course of Cdc42 activation in response to stimulation with DMPP (20 µM; 0, n = 7) as












regulator of an intracellular pathway leading to regulated
exocytosis.
RhoGDI inhibits secretory responsiveness
The activity of the Rho family of GTPases is controlled in
part by RhoGDIs, which inhibit release of GDP from the
GTPase and also control partitioning of the GTPase
between cytosol and membrane compartments. Figure 4A
shows that RhoGDI and Rac1 interact in chromaffin cells,
as immunoprecipitation of endogenous Rac1 from lysate
of cultured chromaffin cells resulted in co-
immunoprecipitation of RhoGDI. In addition,
overexpression of recombinant RhoGDI was capable of
inhibiting Ca2+-dependent secretory responses from
digitonin-permeabilized chromaffin cells (Fig. 4B). The
overexpression of RhoGDI resulted in an approximately
50 % inhibition of hGH secretion monitored at 2 min and
20 % inhibition at 15 min. Figure 4C demonstrates a time-
dependent dialysis of RhoGDI from the permeabilized
cells into the media and correlates with the time-
dependent loss of inhibition by RhoGDI. The inhibitory
effects of RhoGDI on hGH secretion provide additional
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Figure 2. Transfection and expression of Rac1 mutants in chromaffin cells
A, chromaffin cells were co-transfected with plasmids carrying HA epitope-tagged Rac1 mutants, and a
reporter fusion gene (ANP–EmGFP) that is directed to secretory granules of the regulated exocytotic
pathway. Co-expression was evaluated by fluorescence detection of the green fluorescent protein and
immunofluorescent detection of the HA tag using an a-HA antibody. B, quantification of Rac1
immunofluorescence in non-transfected (control, n = 27) and Rac1-V12 (n = 10)-transfected chromaffin
cells. Scale bars = 10 µm.
Figure 3. Effect of co-expression of mutant Rac1 mutants with human growth hormone
(hGH) on hGH secretion in permeabilized chromaffin cells
A, time course of hGH secretion from digitonin-permeabilized chromaffin cells transfected with Rac1-V12
(squares) or an empty parent plasmid (Neo., circles). Secretion was elicited by addition of 30 µM free Ca2+
(filled symbols) and compared to secretion in the absence of Ca2+ (open symbols; n = 3). Co-expression of
hGH serves as a reporter of the regulated exocytotic pathway of transfected cells. B, effect of expression of
Rac1 mutant proteins on Ca2+-evoked hGH secretion at 15 min (n = 9, Rac1-V12 and Rac1-L61; n = 6,
Rac1-N17). Data were normalized to control (Neo.) for comparison between different cell preparations.












evidence that Rac1 plays a regulatory role in the secretory
pathway.
Rac1 modulates secretory responses from intact
chromaffin cells
The effect of expression of recombinant Rac1 on secretion
from intact cells was examined as a further test of
physiological relevance. Figure 5A demonstrates that
expression of dominant active Rac1-V12 or Rac1-L61
significantly enhanced DMPP-induced (20 µM, 2 min)
hGH secretion compared to the empty plasmid control.
The averaged increase in DMPP-induced secretion
mediated by the constitutively active Rac1 constructs
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Figure 4. Effect of RhoGDI expression on Ca2+-dependent secretion from digitonin-
permeabilized chromaffin cells
A, co-immunoprecipitation of RhoGDI (RGDI) with Rac1 from chromaffin cell lysate. Cell lysates were
immunoprecipitated with Rac1 antibody and aliquots of samples subjected to SDS-PAGE and Western
blotting. Blots were probed with a RhoGDI. Lane 1, lysate; 2, immunoprecipitate; 3, supernatant of final
wash. B, effect of expression of RhoGDI on Ca2+-evoked (30 µM) hGH secretion, measured at 2 min (open
bars) and 15 min (filled bars) from permeabilized cells (n = 6). Asterisks represent statistically significant
difference (P < 0.05) from control (Neo.). C, dialysis of RhoGDI from permeabilized chromaffin cells.
Immunoblot lanes, 1, cell lysate; 2 and 3, aliquot of medium collected from permeabilized chromaffin cells
following 2 min and 15 min of Ca2+ stimulation (30 µM), respectively.
Figure 5. Rac1 mutants and RhoGDI alter secretion in intact chromaffin cells
A, effect of constitutively active (V12 and L61) or dominant negative (N17) Rac1 mutants on basal (open
bars) and evoked (filled bars) hGH secretion. Control (Neo.) cells were transfected with empty parent
plasmid. Secretion was evoked by addition of the nACh receptor agonist DMPP (20 µM, 2 min). B, effect of
recombinant RhoGDI expression alone and with Rac1-V12 on basal (open bars) and DMPP-induced
(20 µM, 2 min; filled bars) hGH secretion. Asterisks represent statistically significant difference (P < 0.05)
from control (Neo.). A, Neo, n = 15; Rac1-V12, n = 15; Rac1-L61, n = 3; Rac1-N17, n = 9; B , Neo, n = 21;












(approximately 20–40 %) was somewhat less than that
observed from permeabilized chromaffin cells (approx.
55 %). The Rac1-V12 effect was reduced by lengthening
the period of DMPP stimulation to 15 min (average of
13.7 % increase, n = 6). Expression of Rac1-N17 produced
no significant change from control in the DMPP-induced
hGH secretory response. The enhancement of secretion by
Rac1-V12 in intact cells is consistent with a rapid
activation of Rac1 observed in response to DMPP
stimulation in intact cells and of active Rac1 facilitating
Ca2+-dependent secretion from permeabilized cells. In
addition, expression of RhoGDI in the intact cells
inhibited DMPP-induced secretion by approximately
50 % (Fig. 5B), an effect that paralleled the inhibition
observed on Ca2+-stimulated secretion from
permeabilized cells. Co-expression of Rac1-V12 with
RhoGDI resulted in an amelioration of the inhibitory
effect of RhoGDI on DMPP-induced secretion in intact
chromaffin cells. These data show that Rac1-V12 remains
capable of facilitating secretion in the presence of RhoGDI
overexpression.
Our findings using digitonin-permeabilized cells
demonstrated that constitutively active Rac1 exerts
enhancing effects on secretion downstream of Ca2+. To
determine whether Rac1 expression in intact chromaffin
cells exerted effects on secretion by altering calcium influx
we compared changes in cytosolic calcium induced by
brief localized application of DMPP (20 µM, 10 s) to
control and transfected cells. No significant difference was
found in the averaged peak amplitude (control,
230 ± 47 nM, n = 7; Rac1-V12, 256 ± 26 nM, n = 10; Rac1-
N17, 374 ± 76 nM, n = 9; mean ± S.E.M.) or shape of the
elicited calcium responses monitored by the fluorescent
calcium indicator fura-2 (Molecular Probes, Eugene, OR,
USA). These data are in agreement with a previous report
on chromaffin cells demonstrating no effect of Rac1
inactivation by Clostridium sordellii lethal toxin on
nicotine-evoked Ca2+ responses (Gasman et al. 1999).
To evaluate the effect of Rac1 on the calcium
influx–secretion relationship in single chromaffin cells, we
recorded evoked changes in membrane capacitance
elicited by depolarization mediated calcium influx. Figure
6A shows the stimulus protocol used and a representative
evoked ICa and corresponding DCm recorded from a control
chromaffin cell expressing the ANP–EmGFP protein.
Repetitive depolarizing stimuli resulted in a repeating
cycle of induced ICa (i.e. Ca
2+ influx) and associated
increases in Cm. Figure 6B presents averaged data that
demonstrate the relationship between Ca2+ influx and DCm
for control (ANP–EmGFP) cells with those expressing
recombinant Rac1-V12, and RhoGDI protein. Rac1-V12
expression resulted in a consistent enhancement in
secretory responsiveness with respect to control while
RhoGDI expression decreased responsiveness. No
differences were found in charge density between the
different treatments. Differences in the Ca2+-secretory
releationships were most apparent following the initial few
step-depolarizations, as the level of Ca2+ influx rose. These
data suggest that the primary effect of Rac1 signalling may
not be on an immediate release component. This
interpretation would be consistent with predominant
enhancing effects of Rac1-V12 on secretion being
observed in the slower kinetic assays of hGH secretion
from cell populations.
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Figure 6. Effect of Rac1-V12 and Rho-GDI on the relationship of Ca2+ influx to DCm
A , whole-cell patch clamp recording from a control ANP–EmGFP transfected cell illustrating evoked ICa andDCm responses to a train of repetitive step depolarizations (_90 to +10 mV, 50 ms duration). B, comparison
of relationships between cumulative Ca2+ influx and cumulative DCm for control (ANP–EmGFP, filled
squares, n = 9), Rac1-V12 (filled circles, n = 9) and recombinant RhoGDI (open circles, n = 4) chromaffin
cells. Continuous line represents the standard Ca2+-exocytosis relationship previously described for cultured












Stimulus-induced changes in cortical cytoskeleton
As Rac1 is a central regulator of cytoskeletal organization
the effects of constitutively active Rac1 on secretion may be
associated with localized cytoskeletal reorganization
triggered by the rise in intracellular [Ca2+]. Figure 7A
compares representative examples of the cortical actin
cytoskeleton of control and stimulated (20 µM DMPP,
2 min) chromaffin cells as visualized by Alexa568-
phalloidin labelling. Chromaffin cells were identified by
immunoreactivity to dopamine-b-hydroxylase, an
enzyme essential for noradrenaline synthesis, or by
localization of fluorescence to secretory granules in
ANP–EmGFP transfected cells. In control cells an intense
and nearly continuous band of cortical F-actin staining
was readily apparent adjacent to the membrane. Nicotinic
acetylcholine receptor stimulation resulted in only limited
disruption of perimeter actin staining. The most
prominent observed change to stimulation was an increase
in cytosolic staining for F-actin. Figure 7B shows
representative examples of the F-actin cytoskeleton in
Rac1-V12-transfected cells prior to and following DMPP
stimulation (20 µM, 2 min). Although Rac1-V12 is a
constitutively active GTPase, the cortical actin
cytoskeleton appeared of nearly identical morphology to
that of the non-transfected controls, with only a slight
increase in cytosolic F-actin labelling. Treatment of the
Rac1-V12 transfected cells with DMPP also resulted in
F-actin changes that reflected those of the stimulated, non-
transfected controls, but with an augmentation of
punctate F-actin labelling in the cytosol. Therefore,
transfection with active Rac1-V12 alone did not produce
dramatic alterations in the cortical cytoskeleton, but
increased DMPP-stimulated F-actin reorganization with
respect to control.
Effects of pharmacological modulators of F-actin on
regulated secretion
If Rac1 mediates its effects on secretion by alteration of
cytoskeletal organization then drugs that alter cortical F-
actin should modulate the actions of Rac1. Figure 8A and B
shows that phalloidin (40 µM) or jasplakinolide (100 nM)
treatment of chromaffin cells resulted in an enhancement
of Ca2+-induced secretory or DMPP-induced (20 µM,
2 min) responses, respectively, with respect to control.
Expression of Rac1-V12 strongly facilitated Ca2+-
dependent secretion in these same cell preparations.
However, combination of phalloidin or jasplkinolide with
Rac1-V12 expression resulted in Ca2+-induced secretory
responses that were not significantly different from either
the F-actin modifying drug or Rac1-V12 alone. In
complimentary investigations, treatment of permeabilized
chromaffin cells with latrunculin-A, which avidly binds
G-actin to promote loss of F-actin, resulted in a strong
inhibition of Ca2+-stimulated hGH secretion. Although
Rac1-V12 alone strongly enhanced secretion, latrunculin-
A treatment completely eliminated the ability of Rac1-V12
expression to facilitate hGh secretion.
Action of Rac1 effectors and Rac1 effector domain
mutants on secretion
A primary effector of activated Rac1 is the serine/
threonine protein kinase Pak1. Therefore, we examined if
expression of human Pak1 could mimic the secretory
effect of active Rac1-V12 in response to DMPP
stimulation. Figure 9A shows that overexpression of Pak1
significantly enhanced DMPP (20 mM) evoked secretion
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Figure 7. Effect of nACh receptor activation on
cortical F-actin in bovine chromaffin cells
A, chromaffin cells were identified by dopamine-b-
hydroxylase immunoreactivity and the cortical cytoskeleton
visualized by Alexa568-phalloidin staining. A representative
example of a control and DMPP-stimulated (20 µM, 2 min)
cell is shown. B, visualization of the cortical actin
cytoskeleton by Alexa568-phalloidin in Rac1-V12-
transfected chromaffin cells under control conditions and
following DMPP stimulation (20 µM, 2 min). Chromaffin
cells were identified by cotransfection and expression of
ANP–EmGFP directed to secretory granules. Scale bar in A












from intact chromaffin cells. A potential mechanism for
Rac1–Pak1-mediated enhancement of secretion is via
actions on cytoskeletal reorganization. ADF acts as an F-
actin depolymerization factor that is negatively regulated
by Rac1-Pak1 activation via Lim kinase. Overexpression of
ADF significantly promoted DMPP-induced secretion
relative to control (Fig. 9A). The effects of Pak1 and ADF
on secretion are consistent with an effect of F-actin
reorganization to modulate secretion. No effect was
observed on basal secretion in response to overexpression
of Pak1 or ADF.
Amino acid mutations in the Rac1 effector domain
decrease or eliminate the ability of Rac1 to activate specific
downstream effectors (Self et al. 1993; Joneson et al. 1996;
Lamarche et al. 1996; Tapon et al. 1998). Figure 8B shows
the effects of known effector domain mutations in Rac1-
V12 to alter Ca2+-evoked hGH secretion. Expression of the
T35S and Y40H mutants, which decrease Rac1 signalling
through Pak1, as well as JNK/SAPK, resulted in lowered
secretion compared to control Rac1-V12. Use of a F37L
mutant, which reduces signalling through POR1 and
STAT3, also lowered Ca2+-evoked secretion. As Rac1
effects are limited to evoked versus basal secretion, these
data are consistent with a rapid Ca2+-dependent effect
being mediated through cytoskeletal regulators such as
Pak1 or POR1.
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Figure 8. Effects of pharmacological modifiers of F-actin on secretion in transfected
chromaffin cells
A, effect of phalloidin on Ca2+-evoked hGH secretion from digitonin-permeabilized chromaffin cells (n = 6).
Phalloidin (40 µM) was present during the 2 min permeabilization period and the subsequent 15 min Ca2+
(30 µM) stimulation period. B, representative effect of the membrane-permeant F-actin stabilizing drug
jasplakinolide (100 nM) on hGH secretion from intact chromaffin cells stimulated with DMPP (20 µM,
2 min, n = 3). Effect was replicated in 3 separate cell preparations. C, effect of latrunculin-A on Ca2+-evoked
hGH secretion from digitonin-permeabilized chromaffin cells (n = 3). Latrunculin-A (10 µM) was present
during both the permeabilization period and the 10 min Ca2+ stimulation period. Chromaffin cells were
transfected with the constitutively active Rac1 construct (Rac1-V12) or an empty parent plasmid control
(Neo.), along with the reporter gene hGH, 3 days prior to initiation of secretion assays.
Figure 9. Effects of Rac1 effectors and Rac1-
V12 effector domain mutants on secretion
in transfected chromaffin cells 
A, effect of Pak1 and ADF overexpression on
DMPP-induced (20 µM, 2 min) hGH secretion
from intact chromaffin cells (n = 6). B, effect of
expression of Rac1-V12 and Rac1-V12 effector
domain mutants on Ca2+-induced (30 µM; 15 min)
hGH secretion from digitonin-permeabilized













A role of Rho family GTPases on regulated exocytosis in
chromaffin cells had been previously proposed based on
altered catecholamine secretion following differential
inhibition of Rho family members by clostridial toxins
(Gasman et al. 1999). In this study we provide further
insight on the activation and physiological relevance of
Rac1 in controlling regulated secretion in chromaffin cells.
We demonstrate that: (1) Rac1, but not Cdc42, is rapidly
activated in cells exposed to a nicotinic acetylcholine
receptor agonist or to membrane depolarization induced
by elevated K+; (2) expression of constitutively active
constructs of Rac1 led to enhancement of hGH secretion
in both digitonin-permeabilized and intact chromaffin
cells while recombinant RhoGDI expression inhibited
induced secretion; (3) Rac1 regulation of secretion occurs
downstream of Ca2+ influx; (4) expression of a primary
Rac1 effector, Pak1, also enhanced secretion suggesting
that Rac1 may act via effects on actin cytoskeletal
pathways; and (5) phalloidin and jasplakinolide enhanced
evoked secretion, while latrunculin-A inhibited secretion
and eliminated the enhancing effect of Rac1-V12. Taken
together, the data suggest that Rac1 is activated by
secretory stimuli and acts as a positive physiological
regulator of Ca2+-dependent secretion involving
regulation of the cytoskeleton.
Ca2+-dependent activation of Rac1 to secretory
stimuli
To date, although effects on secretion of endogenous Rho-
family GTPases have been reported from various cell types,
no one has yet examined if the activity of theses GTPases is
regulated by a secretory stimulus. We found that
endogenous Rac1, but not Cdc42, was subject to rapid
activation by secretory stimuli in our highly purified
preparation of cultured chromaffin cells. Furthermore,
activation of Rac1 in response to secretagogue stimulation
was dependent upon Ca2+ influx. The specific GEF
involved in Ca2+-dependent Rac1 activation in chromaffin
cells remains unknown, although a large number of Rho
family GEFs that catalyse exchange of bound GDP for GTP
have been identified (Boguski & McCormick, 1993;
Mackay & Hall, 1998). Support for Ca2+-dependent
activation of Rac1 exists, however, as the GEF Tiam 1 has
been reported to be activated in response to an ionophore-
mediated rise in cytosolic calcium in NIH 3T3 fibroblasts,
perhaps through a pathway involving calcium/calmodulin
kinase II (Fleming et al. 1999; Buchanan et al. 2000). Our
findings show that activation of endogenous Rac1 in
response to sustained secretagogue stimulation of
chromaffin cells was transient. Prolonged fMet-Leu-Phe
(fMLP) or phorbol-12-myristate-13-acetate (PMA)
stimulation of HL-60 cells has also been reported to elicit
only transient activation of Rac2 (Benard et al. 1999).
Activated Rac1 promotes secretion
Our results demonstrate that expression of constitutively
active constructs of Rac1 significantly enhanced stimulus-
induced, Ca2+-dependent secretion. The facilitating effect
on secretion was observed in both early and late phases of
hGH secretion and occurred in both intact and
permeabilized chromaffin cells. In comparison, Rac1-V12
had little effect on basal secretion. The ability of Rac1-V12
to enhance evoked secretion was also observed in Cm
measurements of single chromaffin cells. Indeed, the
electrophysiological results closely correlate to the effects
of Rac1-V12 seen in permeabilized cells, where for a given
calcium concentration a greater secretory response was
obtained. Differences in the Ca2+ influx–DCm relationships
between Rac1-V12 and control were most apparent
following the initial step-depolarizations, suggesting that
the primary effect of Rac1 signalling may be downstream
of an immediate release vesicle pool. The enhancement of
secretion by expression of constitutively active Rac1
mutants extends and promotes analysis of prior reported
results which demonstrated a strong inhibition of
catecholamine secretion following treatment with C.
sordellii lethal toxin, which inactivates endogenous Rac,
but may also target Ras, Ral and Rap1 (Gasman et al.
1999). Our results demonstrate consistently greater effects
of Rac1-V12 on secretion in permeabilized over intact
cells. The mechanism underlying this difference is not
understood. A time-dependent loss of RhoGDI from
permeabilized chromaffin cells may partially account for
the enhanced responsiveness. RhoGDI proteins interact
with GDP-bound Rho family GTPases to depress
nucleotide dissociation and, in general, to direct their
removal from membrane compartments. RhoGDI thus
acts as negative regulator of Rho-family GTPase activity.
Although loss of RhoGDI is unlikely to directly influence
Rac1-V12, this loss may reduce inhibition on endogenous
Rac1 and on other Rho family GTPases that may exert a
permissive or modulatory role on the secretory pathway.
We observed that expression of RhoGDI led to strong
inhibition of evoked secretion in both permeabilized and
intact chromaffin cells. Co-expression of Rac1-V12 with
RhoGDI partially offset the inhibitory effect of RhoGDI on
secretion. These data support an important role of Rac1 in
secretory regulation, but as co-expression did not result in
a full facilitatory effect they also indicate that other Rho
family GTPases may modulate the secretory pathway.
In comparison to Rac1-V12, expression of Rac1-N17 had
no effect on evoked secretion relative to control. One
explanation is that the level of expression of Rac1-N17 was
insufficient to fully inhibit Rac1 GEF activity. We believe
that this is unlikely, as cells were transfected with plasmid
encoding Rac1-N17 at 10 times the plasmid concentration
used to obtain significant enhancement by Rac1-V12, and
evoked secretory responses were still similar to control. In












addition, it is possible that Rac1-N17 in chromaffin cells
exists as a GDP-bound protein (rather than nucleotide
free) and is tightly associated with RhoGDI. Since it is
unlikely that the Rac1 GTPase can interact with a GEF
while bound to RhoGDI, this may explain why it fails to
negatively regulate endogenous Rac1. Consistent with our
findings, Rac1-V12 has been reported to enhance calcium-
induced secretion in permeabilized mast cells, and this
secretory response was found to be relatively resistant to
inhibition by Rac1-N17 (Price et al. 1995). However, in
mast cells secretion is under regulatory control by multiple
GTPases, including Rac2 and Cdc42, which may also
explain a lack of effect of Rac1-N17 on secretion (Brown et
al. 1998).
Cdc42 has previously been proposed in chromaffin cells as
a key regulator coordinating Ca2+-dependent exocytosis
with reorganization of the cytoskeleton (Gasman et al.
1999). This was based largely on the effects of clostridial
toxin inhibition of members of the Rho-GTPase family.
We did not observe an increase of GTP-bound Cdc42 in
response to nicotinic acetylcholine receptor activation.
Therefore, although Cdc42 activity may be necessary for
secretion it may not dynamically regulate Ca2+-dependent
secretion. The relative contribution of the different Rho
family GTPases to regulate secretion may also be cell type
specific as expression of constitutively active and inactive
Rac and Cdc42 mutants in PC-12 cells was reported to
inhibit and enhance secretion for each GTPase,
respectively (Frantz et al. 2002).
Mechanisms of Rac1 action in the secretory pathway
Consistent with the Rho GTPase family as central
mediators of cytoskeletal reorganization in cells, the
facilitating actions of Rac1 on regulated secretion reported
here may operate in part via cytoskeletal regulation. The
sub-plasma-membrane cytoskeleton has often been
proposed to exert a regulatory role in the recruitment,
docking and fusion of secretory granules in chromaffin
cells (Cheek & Burgoyne, 1986; Nakata & Hirokawa, 1992;
Trifaro & Vitale, 1993; Vitale et al. 1995; Plattner et al.
1997; Tchakarov et al. 1998; Lang et al. 2000). For example,
phorbol ester-mediated disruption of the cortical F-actin
network increased the number of chromaffin granules
within 50 nm of the plasma membrane and the rate of
stimulated catecholamine release (Vitale et al. 1995). The
disassembly of the actin cytoskeleton with Clostridium
spiroforme toxin treatment also enhanced the rate of
secretory activity and frequency of unitary exocytic events
measured electrophysiologically in rat melanotrophs
(Chowdhury et al. 1999, 2002). Furthermore, using the
appearance of dopamine-b-hydroxylase on the surface
membrane of chromaffin cells as a marker of exocytotic
activity, DBH became exposed preferentially on plasma
membrane areas devoid of rhodamine–phalloidin staining
in response to stimulation (Nakata & Hirokawa, 1992). In
light of these reports, Rac1 provides a possible molecular
link between secretagogue activation and cytoskeletal
reorganization. A primary Rac1 effector pathway to
cytoskeletal remodelling in fibroblasts involves p21-
activated kinases (PAKs), which are serine/threonine
kinases. Interaction of GTP–Rac1 with Pak1 elicits a
conformational change in Pak1 that results in Pak1
autophosphorylation and activation. Recently, Pak1 has
also been shown to be an important downstream effector
of Rac1 in neurons (Hayashi et al. 2002). Rac1 activation of
Pak leads to phosphorylation of LIM kinase, which
negatively regulates ADF/cofilin, thereby altering the level
of F-actin assembly. In the present study, transfection of
chromaffin cells with Pak1 and ADF expression constructs
significantly enhanced secretion in response to
secretagogue stimulation. Moreover, expression of
effector domain mutants of Rac1-V12 that exhibit reduced
activation of the cytoskeletal regulators Pak and POR1
resulted in a loss of Rac1-V12-mediated enhancement of
evoked secretion. Pak and POR1 thus comprise two
mediators which may act in chromaffin cells to link
secretagogue-induced activation of Rac1 to cytoskeletal
reorganization.
The prevalent hypothesis about the role of cortical actin
cytoskeleton in adrenal chromaffin cells is that it forms a
physical barrier for secretory granule movement to release
sites and that stimulation of secretion induces cortical
actin disruption. However, the extent to which cortical
actin changes on stimulation differs considerably among
published reports, from minimal alterations (e.g. Nakata
& Hirokawa, 1992) to substantial reorganization (e.g.
Cheek & Burgoyne, 1986; Vitale et al. 1991). It also
remains unclear if cortical actin reorganization precedes
or follows exocytotic activity, as exocytotic addition of
vesicle membrane may be visualized as focal actin
reorganization. Moreover, block of nicotine-evoked
secretion with botulinum and tetanus toxins blocks
cortical actin disassembly (Vitale et al. 1991). In the
present study, resolution of cortical F-actin by phalloidin
staining suggested that actin disassembly in response to
brief secretagogue stimulation is of limited extent. This
raises the possibility of effects being very transient and
localized, and has made difficult a definitive assessment of
effects of the cortical cytoskeleton on secretion.
Pharmacological modulators of actin have also been used
to provide evidence that the cytoskeleton may modulate
evoked secretion in chromaffin cells. In general, agents
that stabilize F-actin, such as phalloidin (Lelkes et al. 1986)
and phosphatidylinositol 3-kinase inhibitors (Cheek,
1991; Chasserot-Golaz et al. 1998) have been reported to
inhibit secretion, while agents that disrupt F-actin such as
cytochalasin-D and DNase 1 (Lelkes et al. 1986; Sontag et
al. 1988), latrunculin A (Gil et al. 2000) and gelsolin or
scinderin (Trifaro et al. 1992a) enhance secretion. In the












present study, phalloidin and jasplakinolide, which bind
F-actin to prevent dissociation and to promote actin
monomer association, enhanced secretion and limited
further secretory enhancement by Rac1-V12. An opposite
effect was observed with latrunculin-A, which binds
G-actin to result in F-actin disassembly. The discrepancy
between the present results and those of prior
investigations may be reflective of differences in the
protocols utilized. In the present study, latrunculin A
effects were studied on permeabilized cells rather than on
intact cells (Gil et al. 2000) and in the case of phalloidin
treatment, the cell permeabilization time was limited to
2 min versus 20 min in the prior report (Lelkes et al. 1986).
In addition, treatment of chromaffin cells with clostridial
toxins that block activation of Rho family GTPases greatly
inhibited exocytosis and at the same time disrupted the
peripheral actin cytoskeleton (Gasman et al. 1999). These
results, together with those of the present study suggest
involvement of the cortical cytoskelton in regulation of
secretory responsiveness is likely to be more complicated
than a simple vesicle barrier model.
Recently, the quantification of granule movements in
PC-12 cells has demonstrated that cortical actin limits as
well as mediates secretory granule movement (Lang et al.
2000). Local rather than global reorganization of F-actin
would allow sustained physiological responsiveness while
simultaneously reducing the F-actin barrier to permit
granule fusion with the membrane. Cortical actin may be
required to designate release sites, to tether molecular
mediators, or to serve as a scaffold to provide directional
cues that facilitate supply of vesicles to available release
sites and the readily releasable pool. Notably, a recent
report on the calyx of Held synapse demonstrated that
latrunculin A treatment retards replenishment of
releasable vesicle pools, while phalloidin had no effect
(Sakaba & Neher, 2003). These data are consistent with
F-actin being important to maintenance of sustained
secretion.
Rac1 may enhance secretion through pathways in addition
to those involving the actin cytoskeleton. Indeed, Rac and
Cdc42 have been reported to act at multiple sites to
regulate antigen-stimulated degranulation of RBL-2H3
cells (Hong-Geller & Cerione, 2000). Additional targets of
Rac1 include mixed lineage kinases (MLKs) and the
mitogen activated protein kinases, JNK and p38 (Hall,
1998; Mackay & Hall, 1998; Kaibuchi et al. 1999), which
may have specific roles in regulating gene transcription.
Moreover, Rac and Cdc42 have been reported to directly
interact with specific phospholipases (e.g. PLCb2, PLCg1
and PLD1) and mediate GTP-dependent phospholipase
activation (Hammond et al. 1997; Illenberger et al. 1997,
1998; Hong-Geller & Cerione, 2000; Illenberger et al.
2000), which may further affect the vesicle and/or plasma
membrane configuration at release sites (Humeau et al.
2001). In addition to potential effects of these
phospholipases on PIP2 hydrolysis and second messenger
generation, secretion from chromaffin cells requires the
synthesis of polyphosphoinositides, with the generation of
PIP2 considered as particularly important (Eberhard et al.
1990; Eberhard & Holz, 1991; Hay & Martin, 1993; Holz et
al. 2000). The polyphosphoinositol phosphate synthetic
reactions comprise, in part, the ATP-dependent priming
steps of the secretory cycle and require activity of
phosphatidylinositol 4-phosphate 5-kinase (PIP5K) (Hay
et al. 1995). Of specific interest, Rac and Rho have been
reported to interact and specifically activate the type I
PIP5K (Tolias et al. 1995; Ren & Schwartz, 1998; Carpenter
et al. 1999). Only the type I PIP5K supports PIP2 synthesis
that is essential for ATP-dependent vesicle priming.
Consistent with a role late in the exocytotic pathway, Rac
activity has recently been proposed to be essential
following docking of synaptic vesicles in Aplysia neurons
(Humeau et al. 2002). Clearly, the elucidation of the
downstream signalling pathway(s) by which Rac1
regulates secretion is an important challenge for future
investigations.
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